Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer

Cardiovascular complications are a leading cause of therapy-related morbidity and mortality in long-term survivors of childhood malignancy. In fact, childhood cancer survivors are at a 15-fold risk of developing CHF compared to age-matched controls. There is a strong dose-dependent association betwe...

Full description

Saved in:
Bibliographic Details
Main Authors: Saro H. Armenian, Sarah K. Gelehrter, Eric J. Chow
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2012/713294
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850163974259081216
author Saro H. Armenian
Sarah K. Gelehrter
Eric J. Chow
author_facet Saro H. Armenian
Sarah K. Gelehrter
Eric J. Chow
author_sort Saro H. Armenian
collection DOAJ
description Cardiovascular complications are a leading cause of therapy-related morbidity and mortality in long-term survivors of childhood malignancy. In fact, childhood cancer survivors are at a 15-fold risk of developing CHF compared to age-matched controls. There is a strong dose-dependent association between anthracycline exposure and risk of CHF, and the incidence increases with longer followup. Outcome following diagnosis of CHF is generally poor, with overall survival less than 50% at 5 years. The growing number of childhood cancer survivors makes it imperative that strategies be developed to prevent symptomatic heart disease in this vulnerable population. We present here an overview of the current state of knowledge regarding primary, secondary, and tertiary prevention strategies for childhood cancer survivors at high risk for CHF, drawing on lessons learned from prevention studies in nononcology populations as well as from the more limited experience in cancer survivors.
format Article
id doaj-art-f056e992899f4b54a79a724c34bf9fb1
institution OA Journals
issn 2090-8016
2090-0597
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-f056e992899f4b54a79a724c34bf9fb12025-08-20T02:22:05ZengWileyCardiology Research and Practice2090-80162090-05972012-01-01201210.1155/2012/713294713294Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood CancerSaro H. Armenian0Sarah K. Gelehrter1Eric J. Chow2Department of Population Sciences, City of Hope Comprehensive Cancer Center, 1500 East Duarte Bovlevard, Duarte, CA 91010, USADivision of Pediatric Cardiology, Department of Pediatrics and Communicable Diseases, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI 48109, USAClinical Research and Public Health Science Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USACardiovascular complications are a leading cause of therapy-related morbidity and mortality in long-term survivors of childhood malignancy. In fact, childhood cancer survivors are at a 15-fold risk of developing CHF compared to age-matched controls. There is a strong dose-dependent association between anthracycline exposure and risk of CHF, and the incidence increases with longer followup. Outcome following diagnosis of CHF is generally poor, with overall survival less than 50% at 5 years. The growing number of childhood cancer survivors makes it imperative that strategies be developed to prevent symptomatic heart disease in this vulnerable population. We present here an overview of the current state of knowledge regarding primary, secondary, and tertiary prevention strategies for childhood cancer survivors at high risk for CHF, drawing on lessons learned from prevention studies in nononcology populations as well as from the more limited experience in cancer survivors.http://dx.doi.org/10.1155/2012/713294
spellingShingle Saro H. Armenian
Sarah K. Gelehrter
Eric J. Chow
Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
Cardiology Research and Practice
title Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
title_full Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
title_fullStr Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
title_full_unstemmed Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
title_short Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
title_sort strategies to prevent anthracycline related congestive heart failure in survivors of childhood cancer
url http://dx.doi.org/10.1155/2012/713294
work_keys_str_mv AT saroharmenian strategiestopreventanthracyclinerelatedcongestiveheartfailureinsurvivorsofchildhoodcancer
AT sarahkgelehrter strategiestopreventanthracyclinerelatedcongestiveheartfailureinsurvivorsofchildhoodcancer
AT ericjchow strategiestopreventanthracyclinerelatedcongestiveheartfailureinsurvivorsofchildhoodcancer